Guinea
7 Vaccines Approved for Use in Guinea
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Approval Source: reuters.com
Non Replicating Viral Vector
Gamaleya
Sputnik V
Approved in 74 countries
25 trials in 8 countries
Approval Source: sputniknews.com
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: preventepidemics.org
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Approval Source: preventepidemics.org
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 93 countries
39 trials in 18 countries
Approval Source: preventepidemics.org
Inactivated
Sinovac
CoronaVac
Approved in 56 countries
42 trials in 10 countries
Approval Source: preventepidemics.org
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries
Approval Source: preventepidemics.org
2 in Clinical Trials in Guinea
Non Replicating Viral Vector
Gamaleya
Sputnik V
Approved in 74 countries
25 trials in 8 countries
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 93 countries
39 trials in 18 countries